Xilio Therapeutics Reveals Initial Phase 2 Data for Vilastobart (XTX101) in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer  $XLO, #XilioTherapeutics, #XilioTx
#xlo
#XLO #XilioTherapeutics #XilioTx